Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

XSpray Pharma AB (publ)

Closing information (x1000 EUR)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 168 Less Arrow 61 Less Arrow 0
Earnings before taxes -24,870 More Arrow -16,194 More Arrow -9,455
EBITDA -24,989 More Arrow -16,378 More Arrow -9,578
Total assets 69,329 Less Arrow 68,967 Less Arrow 60,908
Current assets 20,465 Less Arrow 19,630 More Arrow 27,581
Current liabilities 12,723 Less Arrow 3,596 Less Arrow 2,930
Equity capital 54,246 More Arrow 62,492 Less Arrow 57,862
- share capital 3,233 Less Arrow 2,817 Less Arrow 2,022
Employees (average) 26 Equal arrow 26 Less Arrow 22

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2021/12 (consolidated)
Solvency 78.2% More Arrow 90.6% More Arrow 95.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -35.6% More Arrow -23.4% More Arrow -15.5%
Current ratio 160.9% More Arrow 545.9% More Arrow 941.3%
Return on equity (ROE) -45.8% More Arrow -25.9% More Arrow -16.3%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 4 Less Arrow 2
Chg. No. of employees % 0% More Arrow 18% Less Arrow 10%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.